| Argen-X N.V. (Argenx). (6/13/17). "Press Release: Argenx to Present at JMP Securities Life Sciences Conference". Breda & Ghent. |
2017-06-13 |
| MDxHealth S.A.. (6/8/17). "Press Release: MDxHealth Launches CE-Marked SelectMDx IVD PCR Kit and UrNCollect Device [Not for US]". Irvine, CA & Herstal. |
2017-06-08 |
| Biocartis Group N.V.. (6/7/17). "Press Release: MRC Technology and Biocartis Initiate Development of Liquid Biopsy Test for Breast Cancer". London & Mechelen. |
2017-06-07 |
| Eurofins Scientific. (6/1/17). "Press Release: Eurofins Reinforces Its Market Leadership in Environment Testing with the Acquisition of Nab Labs in Finland". |
2017-06-01 |
| Royal Philips. (6/1/17). "Press Release: Philips and Memorial Sloan Kettering Cancer Center Announce Research Agreement to Jointly Develop Advanced Genome Analytics for Precision Oncology". Amsterdam & New York, NY. |
2017-06-01 |
| Royal Philips. (6/1/17). "Press Release: Philips and Illumina Team Up with Navican, an Intermountain Healthcare Company, to Accelerate the Delivery of Precision Medicine to Health Systems Worldwide". Salt Lake City, UT & Amsterdam. |
2017-06-01 |
| Lonza Group Ltd.. (5/30/17). "Press Relase: Lonza Acquires Cell and Gene Contract Manufacturer PharmaCell". Basel. |
2017-05-30 |
| Imcyse S.A.. (5/30/17). "Press Release: Imcyse Obtains Authorization to Launch Phase 1b Trial in Type 1 Diabetes". Liège. |
2017-05-30 |
| Biocartis Group N.V.. (5/23/17). "Press Release: Biocartis Launches CE-marked IVD NRAS Test for Colorectal Cancer". Mechelen. |
2017-05-23 |
| Ablynx N.V.. (5/22/17). "Press Release: Novel Nanobody to Start Clinical Development in Osteoarthritis. Ablynx to Receive €15 Million Milestone Payment". Ghent. |
2017-05-22 |
| Argen-X N.V. (Argenx). (5/19/17). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. |
2017-05-19 |
| Argen-X N.V. (Argenx). (5/18/17). "Press Release: Argenx Raises approximately $100 Million Gross Proceeds with NASDAQ IPO". Breda & Ghent. |
2017-05-18 |
| Vesalius Biocapital Partners Sàrl. (5/18/17). "Press Release: Vesalius Biocapital Announces First Close of Its Third Fund". Bertrange. |
2017-05-18 |
| Biocartis Group N.V.. (5/18/17). "Press Release: Study Demonstrating High Performance of Idylla Liquid Biopsy RAS Tests to be presented at ASCO Annual Meeting". Mechelen. |
2017-05-18 |
| Ogeda S.A.. (5/17/17). "Press Release: Astellas Completes Acquisition of Ogeda SA". Tokyo. |
2017-05-17 |
| Argen-X N.V. (Argenx). (5/16/17). "Press Release: Argenx Announces Size of Initial Public Offering in the United States Increased to 5 million ADSs". Breda & Ghent. |
2017-05-16 |
| Ablynx N.V.. (5/16/17). "Press Release: Ablynx to Present at Upcoming USA Investor Conferences". Ghent. |
2017-05-16 |
| ThromboGenics N.V.. (5/11/17). "Press Release: ThromboGenics Business Update – Q1 2017. Progressing Innovative Diabetic Eye Disease Clinical and Pre-Clinical Portfolio". Leuven. |
2017-05-11 |
| Celyad S.A.. (5/11/17). "Press Release: FDA Grants Fast Track Designation for Celyad’s Ischemic Heart Failure Therapy, C-Cure". Mont-Saint-Guibert. |
2017-05-11 |
| Ablynx N.V.. (5/11/17). "Press Release: Ablynx Reports Financial Results for the First Three Months of 2017 and a Year-to-Date Business Update". Ghent. |
2017-05-11 |
| Norgine B.V.. (5/11/17). "Press Release: Merus Labs and Norgine Enter into a Definitive Arrangment Agreement. Norgine to Acquire All Outstanding Shares of Merus for $1.65 per Share in Cash". Toronto, ON & Amsterdam. |
2017-05-11 |
| Biocartis Group N.V.. (5/10/17). "Press Release: Biocartis Announces Its New CEO". Mechelen. |
2017-05-10 |
| Uniqure N.V.. (5/9/17). "Press Release: Uniqure Announces First Quarter 2017 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. |
2017-05-09 |
| Helsinn Healthcare S.A.. (5/8/17). "Press Release: Helsinn Investment Fund Invests in Aadi Bioscience". Luxembourg. |
2017-05-08 |
| Argen-X N.V. (Argenx). (5/8/17). "Press Release: Argenx Announces Launch of Proposed Initial Public Offering in the United States". Breda & Ghent. |
2017-05-08 |
| Scenic Biotech B.V.. (5/6/17). "Press Release: Scenic Biotech Closes Financing Round". |
2017-05-06 |
| BlueBee. (5/5/17). "Press Release: BlueBee Appoints Two Independent Board Members". Boston, MA & Rijswijk. |
2017-05-05 |
| Eurofins Scientific. (5/4/17). "Press Release: Eurofins Expands Its Clinical Diagnostic Footprint with the Acquisition of Hygel in Germany". |
2017-05-04 |
| Celyad S.A.. (5/3/17). "Press Release: Celyad to Present at the Deutsche Bank 42nd Annual Health Care Conference". Mont-Saint-Guibert. |
2017-05-03 |
| Argen-X N.V. (Argenx). (5/2/17). "Press Release: Argenx Reports First Quarter 2017 Financial Results and Provides Business Update". Breda & Ghent. |
2017-05-02 |
| Qiagen N.V.. (5/2/17). "Press Release: Qiagen Reports Results for First Quarter 2017". Venlo. |
2017-05-02 |
| Gimv. (5/2/17). "Press Release: Gimv Invests in Emerging Immuno-oncology Company ImCheck Therapeutics". Antwerp & Marseille. |
2017-05-02 |
| Celyad S.A.. (5/2/17). "Press Release: Celyad Grants to Novartis a Non-exclusive License for Its Allogeneic TCR-deficient CAR-T Cells Patents". Mont-Saint-Guibert. |
2017-05-02 |
| Noxxon Pharma N.V.. (5/2/17). "Press Release: Noxxon Pharma Secures a Private Placement of €1 Million and Additional Financing of up to €10 Million through Convertible Notes with Share Subscription Warrants Attached to Finance Further Clinical Developmen |
2017-05-02 |
| Qiagen N.V.. (5/2/17). "Press Release: Qiagen Partners with Maccura to Localize and Commercialize GeneReader NGS System in China". Hilden & Chengdu. |
2017-05-02 |
| Ablynx N.V.. (5/2/17). "Press Release: Ablynx Completes Patient Recruitment in Its Phase III HERCULES Study of Caplacizumab for the Treatment of aTTP". Ghent. |
2017-05-02 |
| Uniqure N.V.. (5/1/17). "Press Release: Uniqure Announces Company Presentations at Upcoming May Conferences". Lexington, MA & Amsterdam. |
2017-05-01 |
| Biocartis Group N.V.. (4/27/17). "Press Release: Biocartis Q1 2017 Business Update". Mechelen. |
2017-04-27 |
| Uniqure N.V.. (4/26/17). "Press Release: Uniqure Presents New Preclinical Data on AMT-130 in Huntington’s Disease at CHDI’s 12th Annual Huntington's Disease Therapeutics Conference". Lexington, MA & Amsterdam. |
2017-04-26 |
| Argen-X N.V. (Argenx). (4/26/17). "Press Release: Argenx Announces Results of Annual General Meeting 2017". Breda & Ghent. |
2017-04-26 |
| Uniqure N.V.. (4/25/17). "Press Release: Uniqure Receives European Medicines Agency Priority Medicines (PRIME) Designation for AMT-060 in Hemophilia B". Lexington, MA & Amsterdam. |
2017-04-25 |
| Eurofins Scientific. (4/25/17). "Press Release: Eurofins Reports Continued Strong Momentum with 7% Organic Growth in Q1 2017". |
2017-04-25 |
| Argen-X N.V. (Argenx). (4/24/17). "Press Release: Argenx Files Registration Statement for a Proposed Public Offering in the United States". Breda & Ghent. |
2017-04-24 |
| Galapagos N.V.. (4/21/17). "Press Release: Galapagos Announces Capital Increase". Mechelen. |
2017-04-21 |
| Galapagos N.V.. (4/21/17). "Press Release: Galapagos Announces Closing of Public Offering of American Depositary Shares for Gross Proceeds of €363.9 Million". Mechelen. |
2017-04-21 |
| Biocartis Group N.V.. (4/21/17). "Press Release: Disclosure of a Transparency Notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings)". Mechelen. |
2017-04-21 |
| Uniqure N.V.. (4/20/17). "Press Release: Uniqure Announces It Will Not Seek Marketing Authorization Renewal for Glybera in Europe". Lexington, MA & Amsterdam. |
2017-04-20 |
| Galapagos N.V.. (4/18/17). "Press Release: Galapagos Raises $338 Million Gross Proceeds in a U.S. Public Offering". Mechelen. |
2017-04-18 |
| Galapagos N.V.. (4/17/17). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen. |
2017-04-17 |
| Argen-X N.V. (Argenx). (4/13/17). "Press Release: Argenx Receives First Preclinical Milestone Payment in AbbVie Collaboration". Breda & Ghent. |
2017-04-13 |
| Argen-X N.V. (Argenx). (4/12/17). "Press Release: Argenx Launches Phase II Study of ARGX-110 as a Monotherapy in Relapsed/Refractory CTCL Patients". Breda & Ghent. |
2017-04-12 |
| Genome Diagnostics B.V. (GenDx). (4/10/17). "Press Release: GenDx Signs Global Reseller Agreement for Thermo Fisher Scientific Next-Generation Sequencing Instruments". Utrecht. |
2017-04-10 |
| Transgene S.A.. (4/10/17). "Press Release: Transgene Announces Upcoming Investor Meetings and R&D Day". Strasbourg. |
2017-04-10 |
| Eurofins Scientific. (4/4/17). "Press Release: Eurofins Consolidates Its Market Leadership in Environment Testing in Finland with the Acquisition of Ahma Group". |
2017-04-04 |
| DSM N.V.. (4/3/17). "Press Release: DSM Opens New Biotechnology Center in Delft, the Netherlands". Delft. |
2017-04-03 |
| Ogeda S.A.. (4/3/17). "Press Release: Astellas to Acquire Ogeda SA". Tokyo & Gosselies. |
2017-04-03 |
| Eurofins Scientific. (4/3/17). "Press Release: Eurofins Secures Environment Testing Market Leadership in Finland with the Acquisition of the Laboratory Business of Ramboll Group". |
2017-04-03 |
| MeiraGTx Holdings plc. (3/31/17). "Press Release: MeiraGTx Announces Opening of European Technology Hub". Leiden. |
2017-03-31 |
| Eurofins Scientific. (3/24/17). "Press Release: Eurofins Further Reinforces Its Market Leadership in Environment Testing with the Acquisition of VBM Laboratories in Denmark". |
2017-03-24 |
| VIB, Flanders Interuniversity Institute of Biotechnology. (3/24/17). "Press Release: VIB and DNAlytics Team Up to Develop Non-invasive Colorectal Cancer Screening Test". |
2017-03-24 |
| Evotec AG. (3/23/17). "Press Release: Evotec to Attend Three Upcoming Investor Conferences". Hamburg. |
2017-03-23 |
| Celyad S.A.. (3/23/17). "Press Release: Celyad Reports 2016 Financial and Operating Results and Expected Key Milestones for 2017". Mont-Saint-Guibert. |
2017-03-23 |
| Philips. (3/17/17). "Press Release: Philips Appoints Henk de Jong as Chief of International Markets". Amsterdam. |
2017-03-17 |
| Eurofins Scientific. (3/16/17). "Press Release: Eurofins Expands Its Footprint with the Acquisition of Gözlem Group in Turkey". |
2017-03-16 |
| Eurofins Scientific. (3/15/17). "Press Release: Eurofins Reinforces Asia Pacific Footprint with the Acquisition of Mechem Laboratories in Singapore". |
2017-03-15 |
| Galapagos N.V.. (3/10/17). "Press Release: New Phase 2 Studies with Filgotinib in Small Bowel and Fistulizing Crohn’s disease". Mechelen. |
2017-03-10 |
| Breath Therapeutics Holding B.V.. (3/8/17). "Press Release: Breath Therapeutics Raises EUR 43.5 Million in Series A Financing". Munich, Antwerp, Paris & Utrecht. |
2017-03-08 |
| Gimv. (3/8/17). "Press Release: Gimv Co-leads EUR 43.5 million Financing of Breath Therapeutics". Antwerp. |
2017-03-08 |
| Bruker Corporation. (3/3/17). "Press Release: Alcami Invests in Bruker’s D8 Discover HTS System for High-Throughput X-Ray Diffraction Screening in Pharmaceutical Formulation Development". Weert & Karlsruhe. |
2017-03-03 |
| Uniqure N.V.. (3/1/17). "Press Release: Uniqure Announces Presentations at Upcoming March Conferences". Lexington, MA & Amsterdam. |
2017-03-01 |
| Eurofins Scientific. (2/28/17). "Press Release: Eurofins Achieves Its Recently-upgraded 2016 Objectives and Delivers Its Best Year Ever on Sustained Growth Momentum". |
2017-02-28 |
| Merus N.V.. (2/27/17). "Press Release: Merus to Present at the Cowen & Co. 37th Annual Health Care Conference". Utrecht. |
2017-02-27 |
| Johnson & Johnson. (2/24/17). "Press Release: Darzalex (daratumumab) Receives Positive CHMP Opinion for the Treatment of Multiple Myeloma in Patients who have Received At Least One Prior Therapy". Beerse. |
2017-02-24 |
| Galapagos N.V.. (2/23/17). "Press Release: Galapagos Reports Strong Financial Results and Newsflow-rich Pipeline". Mechelen. |
2017-02-23 |
| Galapagos N.V.. (2/23/17). "Press Release: Galapagos Doses First Healthy Volunteer with CF Combo GLPG2222 and GLPG2451". Mechelen. |
2017-02-23 |
| Vlerick Business School. (2/23/17). "Press Release: Vlerick and KU Leuven Found the Health Sciences & Business Institute Together". |
2017-02-23 |
| Ablynx N.V.. (2/23/17). "Press Release: Ablynx Announces 2016 Rull Year Results. Significant Progress in Key Pre-clinical and Clinical Development Programmes". Ghent. |
2017-02-23 |
| EFPIA. (2/22/17). "Press Release: Nathalie Moll Announced as New EFPIA Director General, Starting in April 2017". |
2017-02-22 |
| TiGenix N.V.. (2/17/17). "Press Release: Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn’s Disease Patients with Cx601". Osaka & Leuven. |
2017-02-17 |
| Noxxon Pharma N.V.. (2/10/17). "Press Release: Noxxon Pharma Announces Experienced Industry Cancer Clinician Dr. Jarl Ulf Jungnelius to Serve as Noxxon CMO". Berlin. |
2017-02-10 |
| Merus N.V.. (2/9/17). "Press Release: Merus to Present at the Leerink Partners 6th Annual Global Healthcare Conference". Utrecht. |
2017-02-09 |
| Forbion Capital Partners. (2/7/17). "Press Release: Forbion Invests in Prexton Therapeutics’ EUR 29 Million (USD 31 Million) Series B Financing". Naarden. |
2017-02-07 |
| Uniqure N.V.. (2/6/17). "Press Release: Uniqure Announces Presentations at Upcoming February Conferences". Lexington, MA & Amsterdam. |
2017-02-06 |
| Ablynx N.V.. (2/6/17). "Press Release: Ablynx Submits a Marketing Authorisation Appolcation to the European Medicines Agency for Caplacizumab, Its anti-vWF Nanobody, for the Treatment of aTTP". Ghent. |
2017-02-06 |
| Euronext N.V.. (2/2/17). "Press Release: Euronext and Biotech Bourse Launch First Quarterly Barometer for Biotech Sector". Amsterdam, et al.. |
2017-02-02 |
| Galapagos N.V.. (2/1/17). "Press Release: Galapagos Doses First Patient with Novel CF Corrector GLPG2222.
IND Opening Triggers $10 Million Milestone Payment from AbbVie". Mechelen. |
2017-02-01 |
| Qiagen N.V.. (2/1/17). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2016". Paris. |
2017-02-01 |
| Bruker Corporation. (1/30/17). "Press Release: Bruker and iTomography Corporation Announce License Agreement for iTomo Image Reconstruction Software". Kontich. |
2017-01-30 |
| ViroVet N.V.. (1/27/17). "Press Release: Dr George Gunn, Former CEO of Novartis Animal Health, Appointed as Chairman at ViroVet". Leuven. |
2017-01-27 |
| ADx NeuroSciences N.V.. (1/26/17). "Press Release: ADx NeuroSciences Receives 850.000 EUR Support from Flemish Government for Tracking Brain Disorders". |
2017-01-26 |
| Caelus Health. (1/26/17). "Press Release: Caelus Health Announces First Closing of a Series A Financing Round to Advance Microbiota-based Therapeutics for Cardio-metabolic Disorders". Amsterdam. |
2017-01-26 |
| Uniqure N.V.. (1/25/17). "Press Release: Uniqure Appoints Alexander Kuta as Senior Vice President of Regulatory Affairs". Lexington, MA & Amsterdam. |
2017-01-25 |
| Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/19/17). "Press Release: Cristal Therapeutics Raises €12.8 Million in New Financing Round to Advance Novel Medicines against Cancer Using Its CriPec Nanotech Platform". Maastricht. |
2017-01-19 |
| Qiagen N.V.. (1/19/17). "Press Release: Qiagen Announces Intention to Adjust the Conversion Ratio under Its 0.375% Senior Unsecured Convertible Notes due 2019 and Its 0.875% Senior Unsecured Convertible Notes due 2021". Venlo. |
2017-01-19 |
| Octimet Oncology N.V.. (1/19/17). "Press Release: Octimet Oncology NV Secures over EUR 11 Million to Develop Its Highly Selective MET kinase Inhibitors". Beerse. |
2017-01-19 |
| Qiagen N.V.. (1/18/17). "Press Release: Qiagen Announces Details for Completion of approximately $250 Million Synthetic Share Repurchase". Venlo. |
2017-01-18 |
| PharmaFluidics N.V.. (1/17/17). "Press Release: PharmaFluidics Raises 2.7 Million Euro to Commercialize Novel Micro-chip Device for Biomarker, Diagnostics and Drug Development Applications". Ghent. |
2017-01-17 |
| Oncurious N.V.. (1/17/17). "Press Release: Oncurious NV Announces European Commission Confirmed Orphan Medicinal Product Designation for TB-403 for Medulloblastoma". Leuven. |
2017-01-17 |
| ViroVet N.V.. (1/10/17). "Press Release: ViroVet Successfully Raises €5 Million in Series A Funding". |
2017-01-10 |
| Royal Philips. (1/9/17). "Press Release: Philips and Illumina Join Forces to Offer Integrated Genomics Solutions for Oncology". Amsterdam & San Diego, CA. |
2017-01-09 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
